We have previously shown that normal-density human peripheral blood eosinophils transcribe and translate mRNA for granulocyte-macrophage colony-stimulating factor (GM-CSF) and that the intracellular distribution was granular as assessed by light microscopy immunocytochemistry. The present study was conducted t o confirm this apparent association between GM-CSF and the crystalloid granule using a subcellular fractionation method for human eosinophils and immunogold electron microscopy (EM). Highly purified ( 3 9 % . by negative selection using anti-CD16 immunomagnetic microbeads) human peripheral blood eosinophils were obtained from four asthmatic subjects (not taking systemic medication), homogenized and density fractionated (5 x lo7 cells/subject) on linear Nycodenz gradients. Twenty-four fractions were collected from each cell preparation and analyzed for marker enzyme activities as well as total protein. Dot blot analysis with specific monoclonal antibodies (MoAbs) was used t o detect the eosinophil granule proteins major basic protein (MBP) and eosinophil cationic protein
( 3 9 % . by negative selection using anti-CD16 immunomagnetic microbeads) human peripheral blood eosinophils were obtained from four asthmatic subjects (not taking systemic medication), homogenized and density fractionated (5 x lo7 cells/subject) on linear Nycodenz gradients. Twenty-four fractions were collected from each cell preparation and analyzed for marker enzyme activities as well as total protein. Dot blot analysis with specific monoclonal antibodies (MoAbs) was used t o detect the eosinophil granule proteins major basic protein (MBP) and eosinophil cationic protein OSINOPHILS are prominent inflammatory cells in allergic inflammation, asthma, and immune reactions against parasitic helminths.' The association between eosinophils and extent of bronchial responsiveness in asthma has been well established (reviewed by Kay) . ' Furthermore, there is substantial evidence, albeit circumstantial, to suggest that activated eosinophils may contribute to airway tissue damage observed in a~t h m a .~ Cytokines, originally considered to be derived predominantly from lymphocytes and monocytes, are now regarded as products of many other cell types. It is clear from studies over the past few years that eosinophils synthesize and secrete several important inflammatory and regulatory cytokines. These include transforming growth factor a (TGFa)? TGFp,5-7 granulocyte-macrophage colony-stimulating factor (GM-CSF),'." interleukin-la (IL-la),12 IL-3: IL-5,",'3,14 IL-6,I5.I6 IL-8," tumor necrosis factor a (TNFa), and macrophage inflammatory protein-la."
GM-CSF is involved in maturation and growth of myeloid progenitors including eosinophil prec~rsors,'~~'~ and in priming, activation and prolongation of survival of the mature eosinophil. 21 It has been suggested that GM-CSF may exert its activities on stimulated eosinophils via an autocrine loop mechanism.' The nature and compartmentalization of eosinophil-derived GM-CSF within the cell are poorly characterized. In our previous report describing GM-CSF mRNA expression in stimulated normal-density eosinophils,' we were also able to detect granule-and cytoplasm-associated immunoreactive GM-CSF, suggesting that this cytokine may reside inside the cell in a stored form. Recent reports have presented evidence that both TNFa and IL-5 may be found in a stored form in eosinophils from patients with eosinophilia caused by the hypereosinophilic ~yndrorne.~'.*~ In this study, we describe the presence of GM-CSF in unstimulated eosinophils from mild asthmatic subjects using a subcellular fractionation technique to show the association of GM-CSF with secretory granules. The presence of stored GM-CSF in hu- (ECP). An anti-CD9 MoAb was used as an eosinophil plasma membrane marker. Lactate dehydrogenase (LDH) was used as a cytosolic marker. Immunoreactivity for GM-CSF was detected by a specific enzyme-linked immunosorbent assay using a polyclonal antihuman GM-CSF antibody and confirmed by dot blot. GM-CSF coeluted with the cellular fractions containing granule markers (MBP, ECP, eosinophil peroxidase, hexosaminidase, and arylsulphatase), but not those containing cytoplasm (LDH+) or membrane (CD97 markers. EM examination of pooled fractions associated with the peak of GM-CSF immunoreactivity confirmed that they contained crystalloid and small granules, but not plasma membrane. In addition, quantification, using immunogold labeling with an anti/GM-CSF MoAb, indicated preferential localization of gold particles over the eosinophil granule cores of intact cells. Thus, our results indicate that GM-CSF resides as a granule-associated, stored mediator in unstimulated human eosinophils. 0 1995 by The American Society of Hematology.
man eosinophils has important implications for the role of this cell in diseases such as asthma in terms of its possible autocrine and paracrine effects on eosinophil activation and survival.
MATERIALS AND METHODS

Materials.
Di-isopropyl fluorophosphate (DFP), leupeptin, aprotinin, Na-p-tosyl-L-arginine methyl ester (TAME), 4-methyl-umbelliferyl-sulphate, 4-methylumbelliferyl N-acetyl-P-D-glucosaminide, o-phenylenediamine, Coomassie Brilliant Blue G-250, P-nicotinamide adenine dinucleotide, reduced form, and sodium pyruvate were all purchased from Sigma Chemical CO (Poole, Dorset, UK). Adenosine triphosphate (ATP) was obtained from Boehringer Mannheim (Mannheim, Germany). Nycodenz was purchased from Nycorned AS Pharma (Oslo, Norway).
Eosinophil pur$cation. A volume of 100 mL of peripheral blood was obtained from mild atopic asthmatics with eosinophilia greater than 10% and who were not receiving oral corticosteroids. After dextran sedimentation of the erythrocytes, a granulocyte pellet was obtained from the remaining leukocytes by density centrifugation on Percoll. Eosinophils were then purified by immunomagnetic selection24 using the magnetic activated cell sorter (MACS) system (Becton Dickinson, Cowley, UK). This method is based on the observation that resting eosinophils, unlike neutrophils, do not express surface CD16." In brief, the granulocyte pellet was incubated (40 minutes, 4°C) with anti-CD16 monoclonal antibody (MoAb) bound to micromagnetic beads (Miltenyi Bio-Tech, Bergisch-Gladbach, Germany). To eliminate any contamination of the eosinophils with mononuclear cells, anti-CD14-and anti-CD3-coated micromagnetic beads (Lab Impex, Teddington, Middlesex, UK) were also added to the anti-CD16/granulocyte mixture. By negative selection, highly purified CD16-eosinophils (>99%) depleted of magnetically positive neutrophils (CD16') and any contaminating mononuclear cells (CD141CD3') were obtained after passage of the granulocytes through a ferrous matrix column held in the field of a permanent magnet. The few contaminating cells were neutrophils.
Frucrionation of human eosinophils. Highly purified human eosinophils (99% pure, 5 X lo7 cells) were treated with 2 mmol/L DFP, a serine proteinase inhibitor, for 5 minutes at room temperature and then sedimented by centrifugation at 240g for 5 minutes. The pellet was resuspended in ice-cold 0.25 mol& sucrose buffer (containing 10 mmoUL HEPES, 1 mmol/L EGTA, and 5 mg/mL each of leupeptin, aprotinin, and TAME, pH 7.4) and the cells were pelleted again at 4°C. Cells were resuspended to the optimal density of I O to 15 X 10h/mL in the above sucrose buffer supplemented with 2 mmol/L MgClz and 1 mmol/L ATP.
For homogenization, the cells were subjected to 8 to 12 passes through a high precision ball-bearing device (EMBL, Heidelberg, Germany) with a clearance of 1 I pm. The postnuclear supernatant, (3 to 4 mL) obtained by centrifugation at 40013 for I O minutes was layered gently onto an 8 mL linear Nycodenz gradient (0% to 45% Nycodenz dissolved in HEPES-buffered sucrose) in a Beckman (High Wycombe, UK) Ultra-Clear centrifuge tube (14 X X9 mm). Nycodenz is a nonionic tri-iodinated density-gradient medium that, unlike sucrose, exhibits relatively low tonicity throughout the gradient. The supernatant was centrifuged to equilibrium density at 100,OOOg for 1 hour at 4°C. Fractions (24 X 0.4 mL) were collected from each preparation. These were stored at 4°C for no longer than overnight, and later at -80°C until used. The density of each fraction was later determined by use of a refractometer. Density (in g/mL) was calculated by the equation 3.4107 -3.555, given by the Nycodenz specification sheet for a solution of Nycodenz using a sucrose diluent, and where h represents the refractive index.
Enzyme assays. The measurement of arylsulphatase activity as a marker for granules and lysosomes was modified from the technique described in Chang et A volume of 50 pL of the fractions (1 OX diluted) was transferred to the wells of black microplates, mixed with 50 mL arylsulphatase substrate solution (10 mmoUL 4-methylumbelliferyl-sulfate in 0.2 mol/L acetate buffer, 6 mmol/L lead acetate, and 0.1% Triton X-100, pH 5.6), and incubated at 37°C for 1 hour. The reaction was terminated by alkalinization by addition of 150 pL of 0.2 molL TRIS, and fluorescence was measured using a Titertek Fluoroskan microplate reader (excitation 340 nm, emission 450 nm). Hexosaminidase activity, which can also mark granular and lysosomal compartments, was measured as previously deTo measure eosinophil peroxidase activity we adapted the method of White et alzx for microtitre plates. The cytosolic enzyme lactate dehydrogenase (LDH) was measured by a method previously de~cribed?~ adapted for use with a mictrotitre plate reader. Absorbance (340 nm) was recorded over 20 minutes at l-minute intervals and the rate of enzyme reaction was calculated by regression analysis over the 20-minute period for each sample. Protein quantitation was performed using the Bradford3" dye-binding protein assay.
Antibodies. For detection of GM-CSF by dot blot, a polyclonal goat-antihuman GM-CSF antibody was used in parallel with its negative control of a goat-antimouse polyclonal antibody (British BioTechnology, Abingdon, UK). Major basic protein (MBP) was detected by an in-house mouse MoAb BMK-13 (Supernatant IgGl ) that has been carefully validated," whereas eosinophil cationic protein (ECP) was detected using EG2 MoAb (Supernatant IgG I, Pharmacia, Uppsala, Sweden). This antibody also cross-reacts with the eosinophil-derived neurotoxin (EDN). Anti-CD9 MoAb (purified IgGI) was purchased from Becton Dickinson. A mouse IgGl antihuman GM-CSF MoAb (a kind gift of Drs T.H. Lee and A. Souza, Guy's Medical School, London, UK) was used for immunogold staining. Normal mouse IgG, anti-CD3 MoAb (supernatant lgGl ),
and anti-CD5 MoAb (purified IgG l ) were used as irrelevant negative controls for the above MoAbs (Becton Dickinson). l m m~n #~y t o~h e m i s t~ jur light microscopy. The alkaline phosphatase antialkaline phosphatase (APAAP) method was performed on cytospins after fixing them in acetone for 90 seconds. Cytospins were air dried and washed in TRIS-buffered saline (TBS) and blocked in 1% bovine serum albumin (BSA) for 30 minutes. AntUGM-CSF was added at a final concentration of I O pg/mL and allowed to incubate overnight at 4°C. Slides were washed in TBS (three times), APAAP-conjugated rabbit antigoat was added at 1 :40 dilution (in 20% normal human serum, 30 minutes). washed and developed with Sigma Fast tablets (Fast Red TWNapthol AS-Mx) under the microscope. The reaction was stopped with H 2 0 and slides were counterstained with hematoxylin (25 seconds) and mounted in glycergel. Appropriate negative controls (TBS only. an irrelevant antibody raised in the same species, anti/GM-CSF antibody in the absence of the second layer and second layer alone) were included.
GM-CSF ELISA. GM-CSF was detected in supernatants using a GM-CSF specific Quantikine ELISA kit (British Biotechnology. Oxford, England), which has a threshold sensitivity of 20 pg/mL. The assay was performed in duplicates of fractionated material Dot-blot analysis. This technique was used to confirm the presence of CM-CSF shown by ELISA and to detect granule-associated proteins (MBP, using BMK-13"; ECPEDN, using EG2) and the eosinophil plasma membrane marker CD9. A total of 2 pL of fraction supernatants were placed on a nitrocellulose membrane, allowed to dry and blocked in 5% milk powder (Sigma). The blotted membrane strips were incubated with the appropriate antibodies and, after extensive washings, incubated with antirabbit biotin followed by streptavidin-alkaline phosphatase and developed. Positive and negative controls were included, as above, and the fractional activities of the markers were assessed by staining density that was given arbitrary units and converted to percent of total activity for each product.
Pooling oj'jructiom , f i w electron microscopy (EM) anu1ysi.v. We examined fractions of one preparation by EM. Fractions containing secretory granule activity (nos. 2 through 6; equivalent densities, 1.2 to 1.24 g/mL) were pelleted after 50% dilution in HEPES-buffered sucrose at 14,OOOg for 15 minutes at 4°C and then fixed. No pellet could be obtained for fractions 7 through 10 (equivalent densities, I , 15 to I . 19 g/mL), which contains a second smaller peak of activity detected in hexosaminidase assays. This has prevented EM analysis of this apparently distinct pool of granule activity. Peak plasma membrane (CD9') activity was pooled from fractions 12 through 18 (equivalent densities, I .07 to 1.13 g/mL). Both pools were centrifuged at 100,000~ for I hour at 4°C and the resulting pellet was fixed for EM examination.
EM. Pelleted fractions were tixed in situ in the centrifuge tube with 2.5% glutaraldehyde in 0.1 mom sodium cacodylate buffer (pH 7.3) followed by cacodylate-buffered 2% osmium tetroxide. The hardened pellet was then detached intact from the base of the tube, bisected and washed in 30% ethanol followed by 50% ethanol. Samples were stained en bloc with saturated uranyl acetate in 50% ethanol and, after completion of ethanol dehydration, embedded in epoxy resin via propylene oxide.
Ultrathin sections were cut using a
For changed into pure resin in gelatine capsules and polymerized using ultraviolet light for 48 hour at -35°C. followed by a further 24 hour polymerization at room temperature). Silver sections were cut as above and picked up onto thin bar (460 TB Hex) nickel grids.
Before labeling, sections were immersed sequentially in the following blocking solutions: I % acetylated BSA (Aurion Ltd) in 0.01 molL PBS, pH 7.2 (5 minutes): 1% BSA in PBS (5 minutes): I% gelatine in PBS (10 minutes): 0.02 molL glycine in PBS. Section were then washed five times in 1% BSA PBS and labeled by immersion in a solution containing mouse antihuman GM-CSF antibody at I :200 in PBS for 16 hours at room temperature. After a I minute wash in PBS, label was visualized by immersion in a goat-antimouse, IO-nm gold, secondary antibody marker system-l:20 in PBS for 75 minutes (Biocell Ltd, Cardiff. UK). Sections were then immersed in I % glutaraldehyde ( I minutes) before being jet washed with distilled water. The following negative controls were also performed: substituting GM-CSF with mouse IgG (1:200) and with l % BSA PBS only.
Qrcunr$ccrfion of immunogold Itheling. Although some grids were counterstained, as for conventional EM, quantification was performed on unstained sections where unequivocal identification of the gold particles was possible. Fifty randomly-selected cells were quantified per treatment (ie, irrespective of their total gold label). Because some of the cells were partially obscured by grid bars, the counts were from a mixture of whole and partially obscured cells. The number of gold particles per granule core, and the number of granules per cell were recorded by counting directly from the electron microscope. Counts were also made of the number of gold particles present over 50 nuclei in each treatment.
Data presentation. The bioactivity of eosinophil granule, membrane, and cytosol constituents after fractionation, including GM-CSF quantitation by enzyme-linked immunosorbent assay (ELISA) (in pglmL) and dot blot, are expressed as frequency distributions according to the method of Beaufay et al." In this method, the fractional activities of the markers are presented as a function of the density for each fraction.
RESULTS
Using the APAAP technique, freshly-prepared cytospins of highly purified eosinophils obtained from asthmatic subjects were examined for GM-CSF immunoreactivity. Positive staining for GM-CSF was found in eosinophils from asthmatic subjects in association with the cytoplasm and/or granules. The mean count of strong positive-staining eosinophils was 21% 2 1% (n = 3, Fig l ) . No immunoreactivity was observed when cells were stained using the irrelevant (negative control) antibody. Eosinophils from normal (nonasthmatic, nonatopic) subjects also showed positive immunostaining for GM-CSF, but at a lower abundance (10.6% 2 1.2%, n = 3). GM-CSF was measured by specific ELISA in disrupted, but not fractionated eosinophils. The mean concentration of stored GM-CSF in eosinophils from asthmatic subjects was 15.1 0.3 pgll0" cells (n = 3). The elution profile of GM-CSF immunoreactivity by ELISA, as well as of ECP (detected by EG2 MoAb in dot blot). peroxidase, and hexosaminidase for four separate fractionations are presented in Fig 2. Hexosaminidase and arylsulphatase showed identical activity profiles in each subfractionation. These activities sedimented as two peaks, suggesting that these two enzymes are localized in subcellular fractions of equivalent density and, therefore, possibly of equivalent structure. Furthermore, the presence of dual peaks of activity suggests the possibility of at least two distinct granule structures in eosinophils. On the other hand, eosinophil peroxidase (EPO) activity was generally confined to a single peak, producing a well-defined second peak in only one preparation (Fig 2) .
GM-CSF coeluted most prominently with EPO activity, measured in fractions having density ranging between I . 18 and 1.23 g/mL. In one preparation (Fig 2), a second 25 . GM-CSF immunoreactivity was also detected. Taken together, these results show colocalization of GM-CSF with fractions containing crystalloid granules. The total concentration of GM-CSF detected by ELISA ranged from 2.7 to 12.7 pg/mL per 10" cells for all fractionations. Dot-blot analysis was used to confirm the identity of GM-CSF in the same fractions, as well as to show immunoreactivity for MBP (by BMK-13) and eosinophil plasma membrane (anti-CD9). Figure 3 is a representative of the four fractionation experiments performed and compares GM-CSF immunoreactivity detected by ELISA with that detected by dot blot analysis. Also shown are the profiles of protein, arylsulphatase, hexosaminidase, MBP, CD9, and, in two experiments, the cytosolic marker LDH. The cytosol, as identified by the presence of LDH activity, was associated with fractions of a density range of 1.03 to 1.07 g/mL and coeluted with the second peak of total protein. A proportion of GM-CSF immunoreactivity (in dot blot analysis) was observed in cytosolic fractions along with hexosaminidase and arylsulphatase activities and is probably derived from granule breakage during homogenization.
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CD9 immunoreactivity was observed in two separate peaks. The first was relatively small and associated with granule MBP immunoreactivity and EPO activity. The larger peak was associated with fractions having a density range of 1.04 to 1.17 g/mL, which is the expected range of densities for plasma membrane-containing fractions."
For EM, fractions were collected into two main pools (Fig 4) . The first constituted the peak of granule activity associated with GM-CSF immunoreactivity, whereas the second contained the peak of CD9 immunoreactivity. Ultrastructural examination confirmed that the first GM-CSF/ associated pool was composed predominantly of secondary crystalloid granules, whereas the second pool consisted of plasma membrane, Golgi, and other membrane fragments, but was devoid of granular structures. An attempt was made to pellet material from the shoulder peak of granule activity seen in the enzyme marker assays (density range. 1.16 to 1.2 g/mL), but the amount of material in these fractions was too small to pellet for EM analysis, even with high-speed centrifugation. Analysis of immunolabeled sections showed low background amounts of gold in all treatments. The secondary antibody/gold control produced very low levels of labeling over granule cores and nuclei, indicating little nonselective interaction between the secondary antibody and cellular ma- 40 -30 - Fig 3. A representative experiment (1 of 4) detailing all the profiles of protein, arylsulphatase (AS), hexosaminidase (Hex), EPO, MBP, CD9, and LDH. together with GM-CSF immunoreactivity in both ELISA and dot-blot analysis.
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For Fraction no. terial. Addition of anti-GM-CSF or mouse IgG caused an increase in the number of gold particles observed ( Table 1) compared with the secondary antibody gold control. The amount of immunolabeling, over the granules, was highest in the anti-GM-CSF-treated sections. The concomitant labeling of the nuclei, although also higher in the anti-GM-CSF sections, was not proportionally as great as the increase found over the granules (Fig 5) .
DISCUSSION
Our results indicate that eosinophil-derived GM-CSF is closely associated with the eosinophil crystalloid granules. This is based on our findings upon subfractionation of the cellular content of eosinophils and examination of the content of each fraction according to density, and by relating these cellular components to the presence of GM-CSF. Parallel coelution of peak GM-CSF immunoreactivity was found with granule, but not cytosolic or plasma membrane markers. The ultrastructural identification of pooled fractions exhibiting this activity indicated the presence of crystalloid secretory granules. The distribution of GM-CSF immunoreactivity was also assessed by EM in intact cells using immunogold labeling. whereby granule cores showed a high affinity for the lahcled antibody.
The fractionation method used succeeded in recovering much of the GM-CSF found stored in disrupted (but not
-
T endocytosed ligand-bound receptors." The latter organelles have not been detected in this work, but they would be expected to equilibrate at a density equivalent to that of plasma membrane. In addition. previous results showing that human eosinophils transcribe and translate GM-CSF' imply that granule-associated GM-CSF is derived from the eosinophil itself. The capacity of eosinophils to synthesize GM-CSF has also been confirmed in nasal tissue and bronchoalveolar lavage, ex vivo"'." in association with allergic disease and asthma.
Arylsulphatase and hexosaminidase. while coeluting with .. . For personal use only. on December 27, 2017. by guest www.bloodjournal.org From both granule proteins and GM-CSF, frequently eluted as a major peak followed by a secondary peak of activity (Figs  2 and 3) . It has been suggested that arylsulphatase may be a stored product of eosinophil small granules3 that, in turn, may be the vestiges of exocytosed crystalloid granule^.^' Alternatively, a proportion of hexosaminidase and arylsulphatase may be stored in a separate population of small granules that are insensitive to secretion signals (K. Larbi and B.D. Gomperts, unpublished observations, May 1994). The elution profile of GM-CSF sometimes resembled that of arylsulphatase and hexosaminidase, which suggests that GM-CSF may also be stored in this lower-density granule population.
The fractionation technique used, combined with EM analysis, provided strong evidence for the colocalization of GM-CSF with the crystalloid granule (Figs 4 and 5) . GM-CSF immunogold was found associated with these granules. A more appropriate measure of the affinity of the antibody for the granules is the ratio between the counts per granule and the counts per nuclei in each sample. Thus, although gold labeling of the nuclei was also greater in the anti/GMCSFltreated sections than in the mouse IgG sections (Table  l) , this increase (2.5 times) was in no way comparable with the increase (10 times) found over the granule cores in the anti/GM-CSFltreated sections. Thus, although, the addition of anti/GM-CSF may cause an increase in nonspecific labeling, a definite specific increase was also found ( Table l) . The precise subgranular site where GM-CSF resides within the two main compartments of the crystalloid granule (ie, core and matrix)35 is not clear. For the purposes of quantification, we have assumed a core location for GM-CSF, an assumption which appears to have been verified. Gold labeling was also found in the areas around the core that were most likely to be the granule matrix. This could not be identified because of the lack of contrast in the unstained sections. Using immunogold labeling, two groups have recently described the presence of two other cytokines, TNF# and IL-5,23 in association with eosinophil granules in patients with eosinophilic conditions; again, precise localization was not possible.
Having established a granule location for GM-CSF, the association between GM-CSF release from eosinophils and independent or concomitant granule proteins exocytosis remains unknown. The pattern of eosinophil exocytosis, especially that of hexosaminidase, in response to a number of agonists has been d~c u m e n t e d .~~-~* However, nothing is known about the relationship between GM-CSF release and eosinophil exocytosis.
Although GM-CSF immunoreactivity was also observed in a subpopulation of eosinophils (10.6%) purified from three nonatopic nonasthmatic control subjects, in the present study we fractionated only asthmatic eosinophils because, in these subjects, large numbers of purified eosinophils required for each fractionation (5 X lo7) can be obtained. The finding that only a proportion (21%) of eosinophils from asthmatic subjects were shown to have immunoreactivity for GM-CSF by light microscopy immunostaining has two important implications. The first argues against the possibility of nonspecific adherence of the anti/GM-CSF antibody. The second suggests that such a subpopulation may also reflect the percentage of in vivolactivated eosinophils found in the peripheral blood of asthmatics that may, in turn, be the source of circulating ECP detected in the peripheral blood in
In conclusion, our results describe the subcellular fractionation of human eosinophils and the colocalization of GM-CSF to the unique crystalloid granules found in these cells. GM-CSF is a vital cytokine for eosinophil growth, maturation, and activation"." and is the most potent of eosinophil survival-promoting cytokines in vitro?' Thus, stored eosinophil-derived GM-CSF in asthmatic subjects may play an important role in prolonging the survival of these cells both in the affected tissue and blood, possibly by delaying apoptosi~.~' This mechanism may be very important in perpetuating and/or exacerbating the eosinophilic inflammatory lesion observed during the asthma process. Indeed, the scope of the endogenous signaling and activation of these cells in asthma may be greater than hitherto appreciated.
